M
Maxine S. Jochelson
Researcher at Memorial Sloan Kettering Cancer Center
Publications - 139
Citations - 5270
Maxine S. Jochelson is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Breast cancer & Mammography. The author has an hindex of 37, co-authored 117 publications receiving 4160 citations. Previous affiliations of Maxine S. Jochelson include Cornell University & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
MRI and Prediction of Pathologic Complete Response in the Breast and Axilla after Neoadjuvant Chemotherapy for Breast Cancer
Joseph J. Weber,Maxine S. Jochelson,Anne Eaton,Emily C. Zabor,Andrea V. Barrio,Mary L. Gemignani,Melissa Pilewskie,Kimberly J. Van Zee,Monica Morrow,Mahmoud El-Tamer +9 more
TL;DR: Radiologic complete response by MRI does not predict pCR with adequate accuracy to replace pathologic evaluation of the breast tumor and axillary nodes.
Journal ArticleDOI
Radiomic signatures with contrast-enhanced magnetic resonance imaging for the assessment of breast cancer receptor status and molecular subtypes: initial results.
Doris Leithner,Joao V. Horvat,Maria Adele Marino,Maria Adele Marino,Blanca Bernard-Davila,Maxine S. Jochelson,R. Elena Ochoa-Albiztegui,Danny F. Martinez,Elizabeth A. Morris,Sunitha B. Thakur,Katja Pinker +10 more
TL;DR: In this preliminary study, radiomic signatures with CE-MRI enable the assessment of breast cancer receptor status and molecular subtypes with high diagnostic accuracy.
Journal ArticleDOI
Residual abdominal masses after chemotherapy for nonseminomatous testicular cancer: correlation of CT and histology
TL;DR: Computed tomographic characteristics of 45 residual masses in 30 patients with disseminated nonseminomatous testicular cancer treated with chemotherapy were correlated with histologic findings at surgery, but it was insufficient to exclude the presence of residual malignancy or teratoma.
Journal ArticleDOI
Is Preoperative Axillary Imaging Beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Lymph Node Dissection?
Melissa Pilewskie,Maxine S. Jochelson,Jessica C. Gooch,Sujata Patil,Michelle Stempel,Monica Morrow +5 more
TL;DR: The axillary lymph node dissection (ALND) in women with less than 3 positive sentinel lymph nodes (SLNs) undergoing breast-conserving surgery (BCS) and radiation therapy was discussed in this paper.
Journal ArticleDOI
Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer
Christopher C. Riedl,Katja Pinker,Katja Pinker,Gary A. Ulaner,Gary A. Ulaner,Leonard Ong,Pascal A. T. Baltzer,Maxine S. Jochelson,Maxine S. Jochelson,Heather L. McArthur,Mithat Gönen,Maura N. Dickler,Wolfgang A. Weber,Wolfgang A. Weber +13 more
TL;DR: In patients with metastatic breast cancer, tumor response on PET/CT appears to be a superior predictor of PFS and DSS than response on CE-CT.